Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dalfampridine in Treatment of Spinal Cord Injury
IRCT20231019059767N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dalfampridine in spinal cord injury (SCI), sponsored by Mashhad University of Medical Sciences. Started Jan 2024; status: completed.
02
Drugs
dalfampridine
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on IRCT20231019059767N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231019059767N1.